Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acq...

por Kuti, Joseph L., Kim, Aryun, Cloutier, Daniel J., Nicolau, David P.
Publicado 2019

Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections

por Armstrong, Eliana S., Mikulca, Janelle A., Cloutier, Daniel J., Bliss, Caleb A., Steenbergen, Judith N.
Publicado 2016

124. Microbiological Outcomes With Plazomicin (PLZ) Versus Meropenem (MEM) in Patients With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in the...

por Keepers, Tiffany R, Cebrik, Deborah S, Cloutier, Daniel J, Komirenko, Allison, Connolly, Lynn, Krause, Kevin
Publicado 2018

1044 Efficacy of Ceftolozane/Tazobactam vs Levofloxacin in the Treatment of Complicated Urinary Tract Infections (cUTI) caused by Levofloxacin-resistant Pathogens: Results from the...

por Sakoulas, George, Umeh, Obiamiwe, Huntington, Jennifer, Cloutier, Daniel, Steenbergen, Judith, Yuan, Guojun, Yoon, Minjung, Goldstein, Ellie
Publicado 2014

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae

por Popejoy, Myra, Cloutier, Daniel, Huntington, Jennifer, Steenbergen, Judith, Hershberger, Ellie, Umeh, Obiamiwe, Miller, Benjamin, Kaye, Keith
Publicado 2014

Surgical site infections following transcatheter apical aortic valve implantation: incidence and management

por Baillot, Richard, Fréchette, Éric, Cloutier, Daniel, Rodès-Cabau, Josep, Doyle, Daniel, Charbonneau, Éric, Mohammadi, Siamak, Dumont, Éric
Publicado 2012

Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection

por Gupta, Sneha V., Fanget, Marie C., MacLauchlin, Christopher, Clausen, Valerie A., Li, Jing, Cloutier, Daniel, Shen, Ling, Robbie, Gabriel J., Mogalian, Erik
Publicado 2021